Assessing the Impact of Single-Use Biomanufacturing Systems

Pharma IQ

Whilst single-use systems have brought many advantages for bioprocessing, such as accelerated downtime and reduced costs, there are still some challenges that need to be addressed. Dr. Kit Erlebach, Head of Technical Commercial Manufacturing at Avecia, and Tony Hitchcock, Head of Process Science at Cobra Biomanufacturing, discuss new single-use technologies in the industry. They examine the potential of these designs over the coming decade, assessing the environmental impact, the...
To continue reading this story get free access